Opzelura (ruxolitinib cream) - Incyte
Jakafi (ruxolitinib) - Incyte
Phototherapy for the Treatment of Acute and Chronic Cutaneous Graft versus Host Disease. (PubMed, Transplant Cell Ther) - Oct 21, 2026 - "Phototherapy is an effective and well-tolerated treatment for cutaneous GVHD, achieving high response rates and facilitating tapering of systemic immunosuppression. Given its favorable safety profile and rapid time to response, phototherapy should be considered as an adjunctive or steroid-sparing option for cutaneous GVHD, particularly in patients with extensive or treatment-refractory disease." 
Journal • Acute Graft versus Host Disease • Chronic Graft versus Host Disease • Genetic Disorders • Graft versus Host Disease • Immunology • Non-melanoma Skin Cancer • Skin Cancer • Solid Tumor • Transplantation
http://www.ncbi.nlm.nih.gov/pubmed/42901276
 
Alina Markova; Andrew C Harris; Anna Chen; Brian Shaffer; Doris M Ponce; Esperanza Papadopoulos; Ian Nykaza; Stephanie Gu; Stephen Dusza
 
Oct 21, 2026
 
Prev Next